Therapeutic Orientation Test in Thrombotic Microangiopathy

计划入组 100 人 · 首次发布于 2021 年 3 月 2 日

Nomacopan (rVA576) in Transplant Associated Thrombotic Microangiopathy

计划入组 10 人 · 首次发布于 2021 年 3 月 5 日

Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger

计划入组 16 人 · 首次发布于 2021 年 2 月 8 日

GPVI inhibitors (thrombotic disorders)

Tirofiban(Aggrastat)

C₂₂H₃₆N₂O₅S · Rx

Caplacizumab(Cablivi)

US THROMBOTIC MICROANGIOPATHY ALLIANCE

United States

Thrombotech Ltd.

Israel

THROMBOSIS RESEARCH INSTITUTE

India

Iptacopan Shows Promise in Treating Life-Threatening Transplant-Associated Thrombotic Microangiopathy

Omeros Corporation's Narsoplimab Meets Primary Endpoint in Pivotal Trial for Stem Cell Transplant Patients

Tandem Stem Cell Transplant Study Reveals Critical Complications in High-Risk Neuroblastoma Treatment